SCHEMBL5433758

SCHEMBL5433758

COc1ccc2c(C)cc(O)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 12/20 0.56
▸ MAPT P10636 6/20 0.56
▸ ALDH1A1 P00352 10/20 0.52
▸ HPGD P15428 4/20 0.52
▸ L3MBTL1 Q9Y468 4/20 0.52
▸ TSHR P16473 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ HBB P68871 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ MPO P05164 1/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ AHR P35869 1/20 0.48
▸ CASP7 P55210 1/20 0.48
▸ POLB P06746 3/20 0.46
▸ LMNA P02545 4/20 0.46
▸ PRNP P04156 1/20 0.46
▸ TLR8 Q9NR97 1/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5798135 0.91 KDM4E (0.49) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL9849499 0.86 POLB (0.62) KDM4EMAPTALDH1A1HPGDTSHR
SCHEMBL24009010 0.82 POLB (0.58) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL8301655 0.79 BACE1 (0.56) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL5427929 0.79 KDM4E (0.52) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL13802956 0.78 KDM4E (0.54) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL8139912 0.76 NPSR1 (0.54) KDM4EALDH1A1HPGDL3MBTL1HSD17B10
SCHEMBL1634865 0.76 MPO (0.60) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL5440887 0.75 MPO (0.46) KDM4EMAPTALDH1A1HPGDTSHR
SCHEMBL4580511 0.75 MDM4 (0.44) KDM4EMAPTALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185079-A1 Therapeutic agents I ASTRAZENECA AB (SE) 2007-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185079-A1 Therapeutic agents I HTT, GRIN2A, GRIN1 KDM4E 2659/4885MAPT 35/4885ALDH1A1 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback